Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 21 Aug 2024 for EyePoint Pharmaceuticals, Inc., €36k. Read the official filing
Filing timeline
BuySaleGoran Ando
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-6.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Goran Ando: trading record in brief
Goran Ando appears in our data through filings on EyePoint, Inc. shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 9 February 2022 and the latest from 21 August 2024.
No open-market sale appears; the market trades are 1 purchase worth €36k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 option exercises. 2024 to date brings 1 purchase and no sales.
On 21 August 2024 came the latest disclosure, an open-market purchase for €36k in EyePoint, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Goran Ando
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
5,000 shares@ US$7.95100.0% of flowCommon StockSEC:0001562180-24-006432:0
Canonical exit: 19 Nov 2024 (T+90)
3,250 shares0Common StockSEC:0001562180-23-001334:0
2,750 shares0Common StockSEC:0001562180-22-001417:0
3 of 3 declarations
